Advanced search
Publication Cover
Journal of Drug Targeting Volume 29, 2021 - Issue 1
Submit an article Journal homepage
562
Views
11
CrossRef citations to date
0
Altmetric
Review Articles

Opportunities and obstacles of targeted therapy and immunotherapy in small cell lung cancer

Lin Yua The Clinical Laboratory of Mianyang Central Hospital, Mianyang, China;b Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, ChinaView further author information
,
Qinhuai Laib Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, ChinaView further author information
,
Lantu Goub Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, ChinaView further author information
,
Jiafu Fenga The Clinical Laboratory of Mianyang Central Hospital, Mianyang, ChinaCorrespondence[email protected]
View further author information
&
Jinliang Yangb Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, ChinaCorrespondence[email protected]
View further author information
Pages 1-11 | Received 09 Feb 2020, Accepted 06 Jul 2020, Published online: 28 Jul 2020

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ehsan Khabazian, Faezeh Vakhshiteh, Parisa Norouzi, Yousef Fatahi, Rassoul Dinarvand & Fatemeh Atyabi. (2022) Cationic liposome decorated with cyclic RGD peptide for targeted delivery of anti-STAT3 siRNA to melanoma cancer cells. Journal of Drug Targeting 30:5, pages 522-533.
Read now

Articles from other publishers (10)

Ayse Ece Gulen, Rakesh Rudraboina, Mohammad Tarique, Vahap Ulker, Haval Shirwan & Esma S. Yolcu. (2023) A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer. Cancer Immunology, Immunotherapy.
Crossref
Yan Zhang, Yafei Li, Qiuxia Fu, Zhiqiang Han, Daijie Wang, Shafiu A. Umar Shinge, Tobias Achu Muluh & Xiaohong Lu. (2023) Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives. Current Cancer Drug Targets 23:4, pages 251-264.
Crossref
Samantha Roudi, Julia Anna Rädler & Samir El Andaloussi. 2023. Precision Medicine in Neurodegenerative Disorders, Part II. Precision Medicine in Neurodegenerative Disorders, Part II 243 266 .
Dhruba Deb, Yangfan Wu, Courtney Coker, Tetsuhiro Harimoto, Ruoqi Huang & Tal Danino. (2022) Design of combination therapy for engineered bacterial therapeutics in non-small cell lung cancer. Scientific Reports 12:1.
Crossref
Chang-Jun Liu, Xiao-Dan Fan, Jian-Guo Jiang, Qiu-Xiong Chen & Wei Zhu. (2022) Potential anticancer activities of securinine and its molecular targets. Phytomedicine 106, pages 154417.
Crossref
Santosh Bashyal, Chhitij Thapa & Sangkil Lee. (2022) Recent progresses in exosome-based systems for targeted drug delivery to the brain. Journal of Controlled Release 348, pages 723-744.
Crossref
Sha Tian, Yinmei Guo, Jiajun Fu, Zijing Li, Jing Li & Xuefei Tian. (2022) Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
Soodeh Salarpour, Mahmood Barani, Abbas Pardakhty, Mehrdad Khatami & Narendra Pal Singh Chauhan. (2022) The application of exosomes and Exosome-nanoparticle in treating brain disorders. Journal of Molecular Liquids 350, pages 118549.
Crossref
Nan Geng, Cui-Min Ding, Zhi-Kun Liu, Shan Song & Wen-Xia Hu. (2021) Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy–refractory extensive-stage SCLC: a real-world retrospective study. International Journal of Clinical Oncology 26:4, pages 670-683.
Crossref
Luca Cantini, Federica Pecci, Filippo Merloni, Andrea Lanese, Edoardo Lenci, Francesco Paoloni, Joachim G.J.V. Aerts & Rossana Berardi. (2021) Old but gold: the role of drug combinations in improving response to immune check-point inhibitors in thoracic malignancies beyond NSCLC. Exploration of Targeted Anti-tumor Therapy.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.